Searched for
AZACITIDINE
US, Venezuela sink Dr Reddy's; five key takeawaysThe slower profit growth was largely because of a decline in volume growth, particularly in the US market and loss of business in Venezuela.26 Jul, 2016, 03.49 PM IST- Intas launches cheaper generic blood cancer drugIntas is manufacturing Azadine at its Ahmedabad facility, which operates in compliance with global regulatory standards like USFDA, MHRA an...20 Jul, 2014, 11.56 AM IST
- Intas Pharmaceuticals prices generic onco-drug at one-fifth of current costIn MDS, the bone marrow does not make enough healthy blood cells and there are abnormal cells present, leading to leukaemia in advanced sta...26 Jun, 2014, 10.26 AM IST
- Dr Reddy's Laboratories posts 76% jump in Q2 net profit at Rs 690 croreGeneric revenues from North America was up 43 per cent at Rs 1,324 crore during the quarter, as against Rs 927 crore in the year-ago period.31 Oct, 2013, 08.07 PM IST
- Brokerages raise price target on Dr Reddy's to as high as Rs 2,720 on FDA nodBrokerages see the FDA approval to Dr Reddy’s Laboratories (DRL) for generic Vidaza as a positive for the company.18 Sep, 2013, 12.29 PM IST
- USFDA approves DRL's Azacitidine for injectionAzacitidine is used to treat certain types of bone marrow cancers and blood cell disorders. Dr Reddy's Azacitidine for injection is availab...17 Sep, 2013, 01.32 PM IST
Load More
